Veeva Systems has reported that the US District Court for the Southern District of New York rejected the trade secret misappropriation lawsuit filed by Dassault Systèmes company Medidata against the former. 

The judge halted the proceedings halfway through the jury trial and dismissed the case, concluding that Medidata had failed to substantiate its allegations against Veeva. 

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

In 2017, Medidata sued Veeva as well as five former staff of Medidata alleging that these employees, who are now employees of Veeva, inappropriately utilised confidential information of Medidata for the benefit of Veeva. 

In a press statement, Veeva said that the ruling is a vital move to protect the rights of employees and customers as the suit involved an attempt to stifle competition and the free talent flow using unfounded trade secret allegations.

Veeva also noted that Medidata filed the trade secret case despite lack of evidence to support the lawsuit and is an attempt to hinder the former’s efforts to innovate in the clinical data management market and to intimidate employees of Medidata from joining Veeva.

The case is claimed to have confused customers of both companies, harmed employees and cost a combined sum of $40m.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Veeva CEO Peter Gassner said: “We are pleased the court dismissed Medidata’s suit and stood up for the rights of employees and customers in the face of an abuse of the legal system, intimidation of employees, and an attempt to limit companies’ access to innovation. 

“Baseless lawsuits like Medidata’s harm individuals, customers, and the industry overall. 

“I hope this ruling encourages others to focus their energy on innovation and employee success rather than unnecessary and harmful litigation.”

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
YPrime won the Innovation award for AI in Clinical Trials and the Environmental award for Sustainable Trials, thanks to its eCOA, IRT and eConsent platforms. Explore how purpose-built AI, paperless workflows and circular hardware practices are reshaping timelines, data quality and ESG performance in clinical research.

Discover the Impact